The page requested for Antigen "Seir Domain Containing Protein/Methionine Sulfoxide Reductase Domain Containing" could not be found. Please take a look at the alternatives listed below, or use the search form above to scan our full portfolio of more than 400.000 antibodies and related products. Thank you!
News
Select Category
All Entries New Antibodies Research News About antibodies-online.com

anti-Histidine decarboxylase and anti-CD117 antibodies in recent publication

Area: Receptors, Angiogenesis
This anti-Histidine decarboxylase antibody and anti-CD117 antibody have recently been used in a publication in Arteriosclerosis, Thrombosis, and Vascular Biology. The authors around Felix C. Tanner investigated the relationship between the Histamin H1 Receptor and the pathogenesis of atherosclerotic lesion formation.
You may find the utilized antibodies here:

Cited anti-Histidine Decarboxylase antibody

Cited anti-CD177 antibody

Additional anti-Histidine decarboxylase antibodies: »Show more anti-Histidine decarboxylase antibodies

Additional anti-CD117 antibodies: »Show more anti-CD117 antibodies

Source: Izabela Rozenberg, Susanna H.M. Sluka, Lucia Rohrer, Janin Hofmann, Burkhard Becher, Alexander Akhmedov, Jorge Soliz, Pavani Mocharla, Jan Borén, Pål Johansen, Jan Steffel, Takeshi Watanabe, Thomas F. Lüscher, and Felix C. Tanner. Histamine H1 Receptor Promotes Atherosclerotic Lesion Formation by Increasing Vascular Permeability for Low-Density Lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology. 2010. Published online before print March 4, 2010, doi: 10.1161/ATVBAHA.109.201079
24.03.2010 | David Kitz Kramer   RSS Feed   New Antibodies   Bookmark and Share

RSS Feed  More Headlines: New Antibodies

RSS Feed  New Antibodies